Your browser doesn't support javascript.
loading
A Review of Cardiac Amyloidosis: Presentation, Diagnosis, and Treatment.
Pour-Ghaz, Issa; Bath, Anandbir; Kayali, Sharif; Alkhatib, Deya; Yedlapati, Neeraja; Rhea, Isaac; Khouzam, Rami N; Jefferies, John L; Nayyar, Mannu.
Affiliation
  • Pour-Ghaz I; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN. Electronic address: ipourghaz@gmail.com.
  • Bath A; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.
  • Kayali S; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.
  • Alkhatib D; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.
  • Yedlapati N; Stern Cardiovascular Foundation, Memphis, TN.
  • Rhea I; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.
  • Khouzam RN; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.
  • Jefferies JL; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN.
  • Nayyar M; Department of Cardiology, Regional One Health, Memphis, TN.
Curr Probl Cardiol ; 47(12): 101366, 2022 Dec.
Article in En | MEDLINE | ID: mdl-35995246
ABSTRACT
Amyloidosis is a group of disorders that can affect almost any organ due to the misfolding of proteins with their subsequent deposition in various tissues, leading to various disease manifestations based on the location. When the heart is involved, amyloidosis can manifest with a multitude of presentations such as heart failure, arrhythmias, orthostatic hypotension, syncope, and pre-syncope. Diagnosis of cardiac amyloidosis can be difficult due to the non-specific nature of symptoms and the relative rarity of the disease. Amyloidosis can remain undiagnosed for years, leading to its high morbidity and mortality due to this delay in diagnosis. Newer imaging modalities, such as cardiac magnetic resonance imaging, advanced echocardiography, and biomarkers, make a timely cardiac amyloidosis diagnosis more feasible. Many treatment options are available, which have provided new hope for this patient population. This manuscript will review the pathology, diagnosis, and treatment options available for cardiac amyloidosis and provide a comprehensive overview of this complicated disease process.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Amyloidosis / Cardiomyopathies Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: Curr Probl Cardiol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Amyloidosis / Cardiomyopathies Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: Curr Probl Cardiol Year: 2022 Document type: Article